Expression of a new isoform of the tumor susceptibility TSG101 protein lacking a leucine zipper domain in Burkitt lymphoma cell lines

Oncogene

Volumn 18, Issue 13, 1999, Pages 2253-2259

  Ferrer, Milagros ^a   López Borges, Susana ^a   Lazo, Pedro A ^a,b  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

^b UNIVERSITY OF SALAMANCA   (Spain)

Author keywords

Aberrant splicing; Burkitt lymphoma; Cancer; Gene expression; Protein isoform; TSG101; Tumor susceptibility gene

Indexed keywords

LEUCINE ZIPPER PROTEIN;

AMINO TERMINAL SEQUENCE; ARTICLE; BURKITT LYMPHOMA; CANCER SUSCEPTIBILITY; CARBOXY TERMINAL SEQUENCE; EXON; LYMPHOMA CELL LINE; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

EID: 0033118236     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1202551     Document Type: Article

References (33)

1. Alber T. (1992). Curr. Opin. Genet. Dev., 2, 205-210.
2. Chomczynski P and Sacchi N. (1987). Anal. Biochem., 162, 156-162.
3. Ehlin-Henrikson B, Manneborg-Sandlund A and Klein G. (1987). Int. J. Cancer, 39, 211-218.
4. Fearon ER. (1997). Science, 278, 1043-1050.
5. Feduchi E, Gallego MI and Lazo PA. (1994). Int. J. Cancer, 58, 855-859.
6. Gayther SA, Barski P, Batley SJ, Li L, de Foy K, Cohen SN, Ponder B and Caldas C. (1997). Oncogene, 15, 2119-2126.
7. Haber D and Harlow E. (1997). Nature Genet., 16, 320-321.
8. Hayashi S, Tanimoto K, Hajiro-Nakanishi K, Kurosomi M, Higashi Y, Imai K, Suga K and Nakachi K. (1997). Cancer Res., 57, 1981-1985.
9. Hershko A. (1997). Curr. Opin. Cell Biol., 9, 788-799.
10. Kinzler KW and Vogelstein B. (1996). Cell, 87, 159-170.
11. Koonin EV and Abagyan RA. (1997). Nat. Genet., 16, 330-331.
12. Lee MP and Feinberg AP. (1997). Cancer Res., 57, 3131-3134.
13. Li L and Cohen SN. (1996). Cell, 85, 315-329.
14. Li L, Li X, Francke U and Cohen SN. (1997). Cell, 88, 143-154.
15. Lin PM, Liu TC, Chang JG, Chen TP and Lin SF. (1998). Br. J. Haematol., 102, 753-758.
16. Magrath I. (1990). Adv. Cancer Res., 53, 133-270.
17. Marklund U, Brattsand G, Osterman O, Ohlsson P and Gullberg M. (1993). J. Biol. Chem., 268, 25671-25680.
18. Oh Y, Proctor ML, Fan YH, Su L-K, Hong WK, Fong KM, Sekido YS, Gazdar AF, Minna JD and Mao L. (1998). Oncogene, 17, 1141-1143.
19. Ponting CP, Cai YD and Bork P. (1997). J. Mol. Med., 75, 467-469.
20. Rabbitts TH. (1994). Nature, 372, 143-149.
21. Rodofsky ML and Lin SL. (1997). Gene, 195, 141-149.
22. Roos G, Brattsand G, Landberg G, Marklund U and Gullberg M. (1993). Leukemia. 7, 1538-1546.
23. Sancho E, Vila MR, Sanchez-Pulido L, Lozano JJ, Paciucci R, Nadal M, Fox M, Harvey C, Bercovich B, Loukili N, Cicchanover A, Lin SL, Sanz F, Estivill X, Valencia A and Thomsom M. (1988). Mol. Cell. Biol., 18, 576-589.
24. Sozzi G, Veronese ML, Negrini M, Baffa R, Cotticelli MG, Inoue H, Tornielli S, Pilotti S, De Gregorio L, Pastorini U, Pierotti MA, Ohta M, Huebner K and Croce CM. (1996). Cell, 85, 17-26.
25. Steiner P, Barnes DM, Harris WH and Weinberg RA. (1997). Nature Genet., 16, 332-333.
26. Sun Z, Pan J, Bubley G and Balk SP. (1997). Oncogene. 18, 3121-3125.
27. Thomson TM, Khalid H, Lozano JJ, Sancho E and Ariño J. (1998). FEBS Lett., 423, 49-52.
28. Townsley FM, Aristarkhov A, Beck S, Hershko A and Ruderman JV. (1997). Proc. Natl. Acad. Sci. USA, 94, 2362-2367.
29. Virgilio L, Shuster M, Gollin SM, Veronese ML, Ohta M, Huebner K and Croce CM. (1996). Proc. Natl. Acad. Sci. USA, 93, 9770-9775.
30. Watanabe M, Yanagi Y, Masuhiro Y, Yano T, Yoshikawa H, Yanagisawa J and Kato S. (1998). Biochem. Biophys. Res. Commun., 245, 900-905.
31. Xie W, Li L and Cohen SN. (1998). Proc. Natl. Acad. Sci. USA, 95, 1595-1600.
32. Zhong Q, Chen C-F, Chen Y, Chen P-L and Lee W-H. (1997). Cancer Res., 57, 4225-4228.
33. Zimonjic D, Druck T, Ohta M, Kastury K, Coce CM, Popescu N and Huebner K. (1997). Cancer Res., 57, 1166-1170.